DHR
Danaher Corporation
Price Chart
Latest Quote
$184.30
-2.34 (-1.25%)
Current Price
| Previous Close | $186.64 |
| Open | $188.00 |
| Day High | $188.75 |
| Day Low | $183.80 |
| Volume | 2,419,689 |
Stock Information
| Quarterly Dividend / Yield | $1.60 / 0.86% |
| Shares Outstanding | 707.77M |
| Quarterly Dividend Yield | 0.86% |
| Quarterly Dividend | $1.60 |
| Total Debt | $19.68B |
| Cash Equivalents | $5.70B |
| Revenue | $24.78B |
| Net Income | $3.68B |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $130.44B |
| P/E Ratio | 35.79 |
| EPS (TTM) | $5.15 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $146.09B |
| Sales | $24.78B |
| Income | $3.68B |
| Book/sh | $74.82 |
| Cash/sh | $8.05 |
| Employees | 58K |
Financial Ratios
| Quick Ratio | 1.40 |
| Current Ratio | 1.87 |
| Debt/Eq | 37.17 |
| EPS Growth TTM | 7.90% |
Returns & Margins
| ROA | 4.19% |
| ROE | 7.08% |
| Gross Margin | 58.99% |
| Operating Margin | 22.94% |
| Profit Margin | 14.89% |
Ownership
| Insider Ownership | 10.74% |
| Institutional Ownership | 84.77% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 20.25 |
| PEG | 1.13 |
| P/S | 5.26 |
| P/B | 2.46 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $244.27 |
Technical Indicators
| SMA20 | $172.90 |
| SMA50 | $180.95 |
| SMA200 | $204.84 |
| RSI | 76.13 |
| ATR | 5.5229 |
| Shares Float | 630.64M |
| Short Float | 1.33% |
| Short Ratio | 1.55 |
| Volatility | 0.83 |
| Rel Volume | 0.51 |
Performance History
| Week | +0.89% |
| Month | +5.36% |
| Quarter | -5.53% |
| 6 Months | -19.05% |
| YTD | -19.84% |
| Year | -3.89% |
| 3 Years | -7.99% |
| 5 Years | -16.94% |
| 10 Years | +352.35% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $184.30 | 2,419,689 |
| 2026-06-04 | $186.64 | 7,771,100 |
| 2026-06-03 | $178.08 | 2,909,800 |
| 2026-06-02 | $176.11 | 2,914,100 |
| 2026-06-01 | $179.87 | 3,652,500 |
| 2026-05-29 | $182.67 | 6,993,100 |
| 2026-05-28 | $180.63 | 5,753,700 |
| 2026-05-27 | $173.13 | 3,264,700 |
| 2026-05-26 | $172.81 | 3,283,100 |
| 2026-05-22 | $172.00 | 2,995,000 |
| 2026-05-21 | $173.33 | 4,237,800 |
| 2026-05-20 | $171.12 | 4,158,800 |
| 2026-05-19 | $167.04 | 5,744,100 |
| 2026-05-18 | $163.86 | 4,955,100 |
| 2026-05-15 | $161.91 | 4,054,000 |
| 2026-05-14 | $164.54 | 4,208,600 |
| 2026-05-13 | $165.99 | 6,526,600 |
| 2026-05-12 | $166.26 | 5,417,200 |
| 2026-05-11 | $166.52 | 7,378,300 |
| 2026-05-08 | $171.16 | 5,846,000 |
| 2026-05-07 | $175.66 | 4,481,900 |
| 2026-05-06 | $174.92 | 5,983,300 |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
đ° Latest News
1 Industrials Stock for Long-Term Investors and 2 That Underwhelm
StockStory âĸ 2026-06-05T10:56:14Z
Jim Cramer on Danaher: âAt These Prices, Itâs Clearly Overvaluedâ
Insider Monkey âĸ 2026-06-04T10:58:30Z
How Corning Turned Glass Into Gold
Trefis âĸ 2026-06-03T12:25:02Z
Is It Time To Reassess Danaher (DHR) After Its Recent Share Price Weakness?
Simply Wall St. âĸ 2026-06-02T16:09:44Z
Here Are Tuesdayâs Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More
24/7 Wall St. âĸ 2026-06-02T12:11:52Z
Avantor (AVTR) Appoints Ludovic Brellier as EVP and Chief Transformation Officer
Insider Monkey âĸ 2026-06-01T11:37:10Z
Is Thermo Fisher Scientific Stock Underperforming the S&P 500?
Barchart âĸ 2026-05-29T15:54:04Z
Teladoc (TDOC) Up 23.9% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-05-29T15:30:23Z
Is Danaher Stock Underperforming the S&P 500?
Barchart âĸ 2026-05-29T14:28:21Z
RBC Capital Resumes Coverage of Danaher Corporation (DHR)
Insider Monkey âĸ 2026-05-26T12:43:07Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $10,045,000,000 | $9,669,000,000 | $9,856,000,000 | $10,455,000,000 |
| Cost Of Revenue | $10,045,000,000 | $9,669,000,000 | $9,856,000,000 | $10,455,000,000 |
| Total Revenue | $24,568,000,000 | $23,875,000,000 | $23,890,000,000 | $26,643,000,000 |
| Operating Revenue | $24,568,000,000 | $23,875,000,000 | $23,890,000,000 | $26,643,000,000 |
| Expenses | ||||
| Interest Expense | $265,000,000 | $278,000,000 | $286,000,000 | $204,000,000 |
| Total Expenses | $19,878,000,000 | $19,012,000,000 | $18,688,000,000 | $19,107,000,000 |
| Other Income Expense | $-222,000,000 | $-56,000,000 | $-175,000,000 | $-227,000,000 |
| Other Non Operating Income Expenses | $6,000,000 | $1,000,000 | $7,000,000 | $44,000,000 |
| Net Non Operating Interest Income Expense | $-235,000,000 | $-161,000,000 | $17,000,000 | $-163,000,000 |
| Interest Expense Non Operating | $265,000,000 | $278,000,000 | $286,000,000 | $204,000,000 |
| Operating Expense | $9,833,000,000 | $9,343,000,000 | $8,832,000,000 | $8,652,000,000 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $3,600,000,000 | $3,899,000,000 | $4,221,000,000 | $6,328,000,000 |
| Net Interest Income | $-235,000,000 | $-161,000,000 | $17,000,000 | $-163,000,000 |
| Interest Income | $30,000,000 | $117,000,000 | $303,000,000 | $41,000,000 |
| Normalized Income | $3,793,800,000 | $3,946,823,000 | $4,373,334,000 | $6,568,106,000 |
| Net Income From Continuing And Discontinued Operation | $3,614,000,000 | $3,899,000,000 | $4,764,000,000 | $7,209,000,000 |
| Total Operating Income As Reported | $4,690,000,000 | $4,863,000,000 | $5,202,000,000 | $7,536,000,000 |
| Net Income Common Stockholders | $3,614,000,000 | $3,899,000,000 | $4,743,000,000 | $7,103,000,000 |
| Net Income | $3,614,000,000 | $3,899,000,000 | $4,764,000,000 | $7,209,000,000 |
| Net Income Including Noncontrolling Interests | $3,614,000,000 | $3,899,000,000 | $4,764,000,000 | $7,209,000,000 |
| Net Income Discontinuous Operations | $14,000,000 | $0 | $543,000,000 | $881,000,000 |
| Net Income Continuous Operations | $3,600,000,000 | $3,899,000,000 | $4,221,000,000 | $6,328,000,000 |
| Pretax Income | $4,233,000,000 | $4,646,000,000 | $5,044,000,000 | $7,146,000,000 |
| Special Income Charges | $20,000,000 | $0 | $0 | $0 |
| Interest Income Non Operating | $30,000,000 | $117,000,000 | $303,000,000 | $41,000,000 |
| Operating Income | $4,690,000,000 | $4,863,000,000 | $5,202,000,000 | $7,536,000,000 |
| Gross Profit | $14,523,000,000 | $14,206,000,000 | $14,034,000,000 | $16,188,000,000 |
| Per Share | ||||
| Diluted EPS | $5.05 | $5.29 | $6.38 | $9.66 |
| Basic EPS | $5.07 | $5.33 | $6.44 | $9.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $-34,200,000 | $-9,177,000 | $-29,666,000 | $-30,894,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $7,173,000,000 | $7,333,000,000 | $7,678,000,000 | $9,753,000,000 |
| Total Unusual Items | $-228,000,000 | $-57,000,000 | $-182,000,000 | $-271,000,000 |
| Total Unusual Items Excluding Goodwill | $-228,000,000 | $-57,000,000 | $-182,000,000 | $-271,000,000 |
| Reconciled Depreciation | $2,447,000,000 | $2,352,000,000 | $2,166,000,000 | $2,132,000,000 |
| EBITDA (Bullshit earnings) | $6,945,000,000 | $7,276,000,000 | $7,496,000,000 | $9,482,000,000 |
| EBIT | $4,498,000,000 | $4,924,000,000 | $5,330,000,000 | $7,350,000,000 |
| Diluted Average Shares | $716,100,000 | $737,200,000 | $743,100,000 | $737,100,000 |
| Basic Average Shares | $712,700,000 | $731,000,000 | $736,500,000 | $725,100,000 |
| Diluted NI Availto Com Stockholders | $3,614,000,000 | $3,899,000,000 | $4,743,000,000 | $7,103,000,000 |
| Tax Provision | $633,000,000 | $747,000,000 | $823,000,000 | $818,000,000 |
| Gain On Sale Of Ppe | $11,000,000 | $0 | $0 | - |
| Gain On Sale Of Business | $9,000,000 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-248,000,000 | $-57,000,000 | $-182,000,000 | $-271,000,000 |
| Research And Development | $1,598,000,000 | $1,584,000,000 | $1,503,000,000 | $1,528,000,000 |
| Selling General And Administration | $8,235,000,000 | $7,759,000,000 | $7,329,000,000 | $7,124,000,000 |
| Preferred Stock Dividends | - | - | $21,000,000 | $106,000,000 |
| Write Off | - | - | $108,000,000 | $91,000,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-05-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-8,434,000,000 | $-9,522,000,000 | $-8,868,000,000 | $-7,015,000,000 |
| Total Assets | $83,464,000,000 | $77,542,000,000 | $84,488,000,000 | $84,350,000,000 |
| Total Non Current Assets | $70,708,000,000 | $68,045,000,000 | $70,551,000,000 | $68,467,000,000 |
| Other Non Current Assets | $4,209,000,000 | $3,990,000,000 | $3,644,000,000 | $7,661,000,000 |
| Goodwill And Other Intangible Assets | $60,968,000,000 | $59,065,000,000 | $62,354,000,000 | $57,097,000,000 |
| Other Intangible Assets | $17,817,000,000 | $18,568,000,000 | $20,746,000,000 | $19,821,000,000 |
| Current Assets | $12,756,000,000 | $9,497,000,000 | $13,937,000,000 | $15,883,000,000 |
| Other Current Assets | $1,739,000,000 | $1,552,000,000 | $1,557,000,000 | $1,741,000,000 |
| Inventory | $2,489,000,000 | $2,330,000,000 | $2,594,000,000 | $2,765,000,000 |
| Receivables | $3,913,000,000 | $3,537,000,000 | $3,922,000,000 | $4,102,000,000 |
| Accounts Receivable | $3,913,000,000 | $3,537,000,000 | $3,922,000,000 | $4,102,000,000 |
| Allowance For Doubtful Accounts Receivable | $-114,000,000 | $-113,000,000 | $-120,000,000 | $-92,000,000 |
| Gross Accounts Receivable | $4,027,000,000 | $3,650,000,000 | $4,042,000,000 | $4,194,000,000 |
| Cash Cash Equivalents And Short Term Investments | $4,615,000,000 | $2,078,000,000 | $5,864,000,000 | $5,995,000,000 |
| Cash And Cash Equivalents | $4,615,000,000 | $2,078,000,000 | $5,864,000,000 | $5,995,000,000 |
| Assets Held For Sale Current | - | - | $0 | $1,280,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $13,803,000,000 | $13,927,000,000 | $12,538,000,000 | $13,682,000,000 |
| Total Debt | $19,696,000,000 | $17,146,000,000 | $19,536,000,000 | $20,616,000,000 |
| Long Term Debt And Capital Lease Obligation | $19,495,000,000 | $16,468,000,000 | $17,661,000,000 | $19,858,000,000 |
| Long Term Debt | $18,416,000,000 | $15,500,000,000 | $16,707,000,000 | $19,086,000,000 |
| Current Debt And Capital Lease Obligation | $201,000,000 | $678,000,000 | $1,875,000,000 | $758,000,000 |
| Current Debt | $2,000,000 | $505,000,000 | $1,695,000,000 | $591,000,000 |
| Other Current Borrowings | $2,000,000 | $505,000,000 | $1,695,000,000 | $591,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $30,923,000,000 | $27,992,000,000 | $30,998,000,000 | $34,260,000,000 |
| Total Non Current Liabilities Net Minority Interest | $24,116,000,000 | $21,194,000,000 | $22,724,000,000 | $25,871,000,000 |
| Other Non Current Liabilities | $184,000,000 | $214,000,000 | $228,000,000 | $261,000,000 |
| Derivative Product Liabilities | $0 | $0 | - | - |
| Tradeand Other Payables Non Current | $3,231,000,000 | $3,425,000,000 | $3,782,000,000 | $4,548,000,000 |
| Non Current Deferred Liabilities | $231,000,000 | $232,000,000 | $249,000,000 | $221,000,000 |
| Current Liabilities | $6,807,000,000 | $6,798,000,000 | $8,274,000,000 | $8,389,000,000 |
| Other Current Liabilities | $1,368,000,000 | $1,083,000,000 | $1,172,000,000 | $2,230,000,000 |
| Current Deferred Liabilities | $1,353,000,000 | $1,299,000,000 | $1,465,000,000 | $1,456,000,000 |
| Payables And Accrued Expenses | $2,451,000,000 | $2,396,000,000 | $2,423,000,000 | $2,552,000,000 |
| Payables | $2,451,000,000 | $2,396,000,000 | $2,423,000,000 | $2,552,000,000 |
| Other Payable | $75,000,000 | $75,000,000 | $75,000,000 | $75,000,000 |
| Total Tax Payable | $532,000,000 | $568,000,000 | $582,000,000 | $621,000,000 |
| Accounts Payable | $1,844,000,000 | $1,753,000,000 | $1,766,000,000 | $1,856,000,000 |
| Liabilities Heldfor Sale Non Current | - | - | $0 | $287,000,000 |
| Equity | ||||
| Common Stock Equity | $52,534,000,000 | $49,543,000,000 | $53,486,000,000 | $48,414,000,000 |
| Total Equity Gross Minority Interest | $52,541,000,000 | $49,550,000,000 | $53,490,000,000 | $50,090,000,000 |
| Stockholders Equity | $52,534,000,000 | $49,543,000,000 | $53,486,000,000 | $50,082,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-207,000,000 | $-3,218,000,000 | $-1,748,000,000 | $-2,872,000,000 |
| Other Equity Adjustments | $-207,000,000 | $-3,218,000,000 | $-1,748,000,000 | $-2,872,000,000 |
| Retained Earnings | $46,891,000,000 | $44,188,000,000 | $41,074,000,000 | $39,205,000,000 |
| Preferred Stock Equity | - | - | - | $1,668,000,000 |
| Other | ||||
| Treasury Shares Number | $180,000,000 | $165,200,000 | $141,300,000 | $141,000,000 |
| Ordinary Shares Number | $706,900,000 | $719,100,000 | $739,200,000 | $728,300,000 |
| Share Issued | $886,900,000 | $884,300,000 | $880,500,000 | $869,300,000 |
| Tangible Book Value | $-8,434,000,000 | $-9,522,000,000 | $-8,868,000,000 | $-8,683,000,000 |
| Invested Capital | $70,952,000,000 | $65,548,000,000 | $71,888,000,000 | $68,091,000,000 |
| Working Capital | $5,949,000,000 | $2,699,000,000 | $5,663,000,000 | $7,494,000,000 |
| Capital Lease Obligations | $1,278,000,000 | $1,141,000,000 | $1,134,000,000 | $939,000,000 |
| Total Capitalization | $70,950,000,000 | $65,043,000,000 | $70,193,000,000 | $69,168,000,000 |
| Minority Interest | $7,000,000 | $7,000,000 | $4,000,000 | $8,000,000 |
| Treasury Stock | $11,353,000,000 | $8,163,000,000 | $2,019,000,000 | - |
| Additional Paid In Capital | $17,194,000,000 | $16,727,000,000 | $16,170,000,000 | $12,072,000,000 |
| Capital Stock | $9,000,000 | $9,000,000 | $9,000,000 | $1,677,000,000 |
| Common Stock | $9,000,000 | $9,000,000 | $9,000,000 | $9,000,000 |
| Employee Benefits | $968,000,000 | $849,000,000 | $798,000,000 | $690,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $608,000,000 | $560,000,000 | $544,000,000 | $492,000,000 |
| Non Current Deferred Revenue | $231,000,000 | $232,000,000 | $249,000,000 | $221,000,000 |
| Long Term Capital Lease Obligation | $1,079,000,000 | $968,000,000 | $954,000,000 | $772,000,000 |
| Long Term Provisions | $7,000,000 | $6,000,000 | $6,000,000 | $6,000,000 |
| Current Deferred Revenue | $1,353,000,000 | $1,299,000,000 | $1,465,000,000 | $1,456,000,000 |
| Current Capital Lease Obligation | $199,000,000 | $173,000,000 | $180,000,000 | $167,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,247,000,000 | $1,157,000,000 | $1,184,000,000 | $1,222,000,000 |
| Current Provisions | $187,000,000 | $185,000,000 | $155,000,000 | $171,000,000 |
| Goodwill | $43,151,000,000 | $40,497,000,000 | $41,608,000,000 | $37,276,000,000 |
| Net PPE | $5,531,000,000 | $4,990,000,000 | $4,553,000,000 | $3,709,000,000 |
| Accumulated Depreciation | $-4,767,000,000 | $-4,101,000,000 | $-3,826,000,000 | $-3,433,000,000 |
| Gross PPE | $10,298,000,000 | $9,091,000,000 | $8,379,000,000 | $7,142,000,000 |
| Other Properties | $2,144,000,000 | $1,883,000,000 | $1,794,000,000 | $1,669,000,000 |
| Machinery Furniture Equipment | $4,867,000,000 | $4,430,000,000 | $4,106,000,000 | $3,477,000,000 |
| Buildings And Improvements | $3,054,000,000 | $2,548,000,000 | $2,269,000,000 | $1,795,000,000 |
| Land And Improvements | $233,000,000 | $230,000,000 | $210,000,000 | $201,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,287,000,000 | $1,145,000,000 | $1,282,000,000 | $1,359,000,000 |
| Work In Process | $469,000,000 | $465,000,000 | $459,000,000 | $422,000,000 |
| Raw Materials | $733,000,000 | $720,000,000 | $853,000,000 | $984,000,000 |
| Preferred Shares Number | - | $1,720,000 | $1,720,000 | $1,720,000 |
| Preferred Stock | - | $0 | $0 | $1,668,000,000 |
Fetched: 2026-05-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $5,260,000,000 | $5,296,000,000 | $5,781,000,000 | $7,401,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $6,416,000,000 | $6,688,000,000 | $7,164,000,000 | $8,519,000,000 |
| Cash From Discontinued Operating Activities | $0 | $0 | $674,000,000 | $906,000,000 |
| Cash Flow From Continuing Operating Activities | $6,416,000,000 | $6,688,000,000 | $6,490,000,000 | $7,613,000,000 |
| Operating Gains Losses | $228,000,000 | $57,000,000 | $182,000,000 | $271,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,156,000,000 | $-1,392,000,000 | $-1,383,000,000 | $-1,118,000,000 |
| Investing Cash Flow | $-1,196,000,000 | $-1,981,000,000 | $-7,081,000,000 | $-2,234,000,000 |
| Cash From Discontinued Investing Activities | $0 | $0 | $-33,000,000 | $-89,000,000 |
| Cash Flow From Continuing Investing Activities | $-1,196,000,000 | $-1,981,000,000 | $-7,048,000,000 | $-2,145,000,000 |
| Net Other Investing Changes | $33,000,000 | $34,000,000 | $44,000,000 | $51,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-3,088,000,000 | $-5,979,000,000 | $0 | $0 |
| Issuance Of Capital Stock | $85,000,000 | $162,000,000 | $68,000,000 | $31,000,000 |
| Financing Cash Flow | $-2,961,000,000 | $-8,385,000,000 | $-273,000,000 | $-2,570,000,000 |
| Cash Flow From Continuing Financing Activities | $-2,961,000,000 | $-8,385,000,000 | $-273,000,000 | $-2,570,000,000 |
| Net Other Financing Charges | $-125,000,000 | $-131,000,000 | $2,533,000,000 | $-95,000,000 |
| Cash Dividends Paid | $-878,000,000 | $-768,000,000 | $-1,248,000,000 | $-818,000,000 |
| Net Common Stock Issuance | $-3,003,000,000 | $-5,817,000,000 | $68,000,000 | $31,000,000 |
| Common Stock Issuance | $85,000,000 | $162,000,000 | $68,000,000 | $31,000,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-500,000,000 | $-1,674,000,000 | $-620,000,000 | $-965,000,000 |
| Issuance Of Debt | $1,556,000,000 | $0 | $0 | $0 |
| End Cash Position | $4,615,000,000 | $2,078,000,000 | $5,864,000,000 | $5,995,000,000 |
| Beginning Cash Position | $2,078,000,000 | $5,864,000,000 | $5,995,000,000 | $2,586,000,000 |
| Effect Of Exchange Rate Changes | $278,000,000 | $-108,000,000 | $59,000,000 | $-306,000,000 |
| Changes In Cash | $2,259,000,000 | $-3,678,000,000 | $-190,000,000 | $3,715,000,000 |
| Common Stock Payments | $-3,088,000,000 | $-5,979,000,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $1,045,000,000 | $-1,669,000,000 | $-1,626,000,000 | $-1,688,000,000 |
| Net Short Term Debt Issuance | $-11,000,000 | $5,000,000 | $-1,006,000,000 | $-723,000,000 |
| Net Long Term Debt Issuance | $1,056,000,000 | $-1,674,000,000 | $-620,000,000 | $-965,000,000 |
| Long Term Debt Payments | $-500,000,000 | $-1,674,000,000 | $-620,000,000 | $-965,000,000 |
| Long Term Debt Issuance | $1,556,000,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $-115,000,000 | $-78,000,000 | $-111,000,000 | $-505,000,000 |
| Sale Of Investment | $12,000,000 | $253,000,000 | $61,000,000 | $18,000,000 |
| Purchase Of Investment | $-127,000,000 | $-331,000,000 | $-172,000,000 | $-523,000,000 |
| Net Business Purchase And Sale | $9,000,000 | $-558,000,000 | $-5,610,000,000 | $-582,000,000 |
| Sale Of Business | $9,000,000 | $0 | $0 | $0 |
| Purchase Of Business | $0 | $-558,000,000 | $-5,610,000,000 | $-582,000,000 |
| Net PPE Purchase And Sale | $-1,123,000,000 | $-1,379,000,000 | $-1,371,000,000 | $-1,109,000,000 |
| Sale Of PPE | $33,000,000 | $13,000,000 | $12,000,000 | $9,000,000 |
| Purchase Of PPE | $-1,156,000,000 | $-1,392,000,000 | $-1,383,000,000 | $-1,118,000,000 |
| Change In Working Capital | $-719,000,000 | $-198,000,000 | $-470,000,000 | $-1,413,000,000 |
| Change In Other Working Capital | $-440,000,000 | $-483,000,000 | $-1,204,000,000 | $-582,000,000 |
| Change In Payables And Accrued Expense | $50,000,000 | $-467,000,000 | $-192,000,000 | $79,000,000 |
| Change In Accrued Expense | $41,000,000 | $-486,000,000 | $-43,000,000 | $97,000,000 |
| Change In Payable | $9,000,000 | $19,000,000 | $-149,000,000 | $-18,000,000 |
| Change In Account Payable | $9,000,000 | $19,000,000 | $-149,000,000 | $-18,000,000 |
| Change In Prepaid Assets | $-55,000,000 | $274,000,000 | $419,000,000 | $-73,000,000 |
| Change In Inventory | $-58,000,000 | $147,000,000 | $185,000,000 | $-448,000,000 |
| Change In Receivables | $-216,000,000 | $331,000,000 | $322,000,000 | $-389,000,000 |
| Changes In Account Receivables | $-216,000,000 | $331,000,000 | $322,000,000 | $-389,000,000 |
| Stock Based Compensation | $298,000,000 | $288,000,000 | $306,000,000 | $295,000,000 |
| Asset Impairment Charge | $562,000,000 | $265,000,000 | $77,000,000 | $0 |
| Depreciation Amortization Depletion | $2,447,000,000 | $2,352,000,000 | $2,166,000,000 | $2,132,000,000 |
| Depreciation And Amortization | $2,447,000,000 | $2,352,000,000 | $2,166,000,000 | $2,132,000,000 |
| Amortization Cash Flow | $1,697,000,000 | $1,631,000,000 | $1,491,000,000 | $1,434,000,000 |
| Amortization Of Intangibles | $1,697,000,000 | $1,631,000,000 | $1,491,000,000 | $1,434,000,000 |
| Depreciation | $750,000,000 | $721,000,000 | $675,000,000 | $698,000,000 |
| Gain Loss On Investment Securities | $228,000,000 | $57,000,000 | $182,000,000 | $271,000,000 |
| Net Income From Continuing Operations | $3,600,000,000 | $3,899,000,000 | $4,221,000,000 | $6,328,000,000 |
| Other Non Cash Items | - | $25,000,000 | $8,000,000 | - |
| Gain Loss On Sale Of Business | - | - | $182,000,000 | $271,000,000 |
Fetched: 2026-05-22